Author

R. I. Levy

Observed names: R I Levy, R. I. LEVY

Observed institutions: National Institutes of Health, National Heart, Lung, and Blood Institute

OpenAlex ID: A5113665784

A New Mechanism of Exogenous Hyperglyceridemia

1969 · C. J. GLUECK, A. P. KAPLAN, et al. · Annals of Internal Medicine · 66

Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.

1976 · J L Kyner, R I Levy, et al. · PubMed · 8

Clinical Experience with Fluvastatin, the First Synthetic HMG-CoA Reductase Inhibitor

1993 · L. A. Jokubaitis, A. J. Troendle, et al. · Medical science symposia series · 4

Nutrition in health and disease, Vol. 1. Nutrition, lipids, and coronary heart disease. A global view.

1979 · R. I. Levy, Basil M. Rifkind, et al. · 1

Effects of Chenodeoxycholic Acid (CD) Treatment on Endogenous Plasma Triglyceride (TG) Transport in Hyperlipoproteinemia (HLP)

1978 · B. Angelin, K. Einarsson, et al. · Advances in experimental medicine and biology

Beta lipoprotein protein turnover: an approach to the understanding of drug and disease mechanisms.

1972 · R I Levy · PubMed

Works count: 6

Citation count: 79

H-index: 3

I10-index: 1